Mateusz Pospiech is a Postdoctoral Scholar at the University of Southern California, School of Pharmacy. Mateusz's research focuses on  neoantigents and characterization of TCR repertoire of acute myeloid leukaemia and their function in the development of personalized cell therapies.

Mateusz received his undergraduate and graduate degree in Chemistry from Poland. He purused a PhD from Swasnea University Medical School, under the mentorship of Professor Martin Sheldon where he focused on the use of bisphosphonate inhibitors of squalene synthase to provide cytoprotection against cholesterol-dependent cytolysins.

Email: pospiech@usc.edu  

Soheila is our new postdoctoral researcher.  Before joining our lab, Soheila was as a Postdoctoral Researcher in the group of Prof. Waldmann at Max Planck Institute of Molecular Physiology in Germany. She studied characterization of biologically active molecules that have been identified as hit substances in a high-throughput phenotypic screening to determine their target or mode of action as potential drug targets by utilizing a wide range of cellular biology methods as well as cell painting methods. 

She earned her PhD in Biochemistry, Biophysics and Molecular Biology from medical faculty of University of Düsseldorf, where she conducted research on the understanding the molecular mechanism of signal transduction pathways such as RAS signaling using biophysical and biochemical methods. She has developed skills in Cell Biology, Biochemistry, Biophysics, Molecular & Cellular Biology, and various analytical and experimental techniques.

Email: soheila.rezaei@usc.edu

Xiaochen is a second year Master in Clinical and Experimental Patient Therapeutics (CXPT). She earned her bachelor's degree in Pharmacy at Zhengzhou University. 

Her research project entails establishing and characterizing a Cre-inducible apolipoprotein C2 (Apoc2) knockout mouse models to study the rules of Apoc2 in normal hematopoiesis. 

Email: xzhang39@usc.edu

Shephali is a second year Master in Pharmaceutical Sciences (PSCI). She earned her bachelor’s degree in Pharmacy and MBA in Pharmaceutical Technology at NMIMS university.

Her research mainly focuses on characterizing the effects of CD99 on T cells.

email: shephali@usc.edu

Kanaka is a second year Master's student in Molecular Pharmacology and Toxicology (MPTX). She completed her Bachelor's degree in Pharmacy from University of Mumbai. 

Her research focuses on examining the role of Apolipoprotein C2 (APOC2) in Hypomethylating agent (HMA) therapy resistance in Acute Myeloid Leukemia (AML) and exploiting the APOC2-CD36 axis as a treatment strategy to sensitize AML to HMAs.

Email: kdhuri@usc.edu

Wenda is a first-year Master's student in Pharmaceutical Sciences at USC School of Pharmacy. He received his undergraduate degree from Southeast University in China. 

Email: wendazhu@usc.edu

Qianqian Peng is a first-year Master's student in Pharmaceutical Sciences at USC School of Pharmacy. She received her undergraduate degree from The Ohio State University.  

Email: pengqian@usc.edu

Yiyu Xiao is a first-year Master student in Pharmaceutical Sciences at USC School of Pharmacy. She earned her undergraduate degree in Sun Yat-Sen University in China.

Email: yiyuxiao@usc.edu

Ryan is a third Year Undergraduate pursuing a B.S. in Pharmacology and Drug Development. 

His research mainly focuses on midostaurin-resistant AML cells and their response to FLT3/CD99 targeting. 

Email: rlchu@usc.edu